What Algorithmiq does

Algorithmiq is a European quantum-software company that develops hybrid quantum-classical algorithms and error-mitigation techniques targeting problems in life sciences, chemistry, and material science. Founded in 2020 in Helsinki and relocated to Milan in 2026, the company is built around two patented inventions — Tensor-Network Error Mitigation (TEM) and the Digital Quantum Interface (DQI) — plus a patent-pending circuit-optimisation method (Treespilation). Its flagship product, the Aurora platform, combines these with specialised toolboxes (Measurement, Error Mitigation, Circuit Optimisation) to enable hardware-agnostic execution on IBM, Microsoft Azure Quantum, Rigetti, QuEra, Quantum Circuits, OQC, and Equal1 hardware. The TEM service is commercially available as a callable function on IBM's Qiskit Functions Catalog, and an NVIDIA GPU-accelerated version demonstrated a 300x speedup. Customers and partners include Cleveland Clinic, Fraunhofer ISC, the UK National Quantum Computing Centre, CERN, EPFL, Trinity College Dublin, and the Flatiron Institute, with use cases spanning drug discovery (including an award-winning photodynamic-therapy workflow), drug-metabolism prediction, materials design, and financial fraud detection.

Algorithmiq monetises through a mix of recurring enterprise licensing for Aurora and bespoke R&D collaborations, usage-based consumption via IBM Qiskit Functions and Microsoft Azure Quantum marketplaces, hardware-vendor co-development agreements, and non-dilutive prize income (notably the $2M Wellcome Leap Q4Bio Challenge won in April 2026). The company does not publicly disclose pricing; engagements are quoted and negotiated per customer. Go-to-market combines API-first distribution through cloud marketplaces, enterprise field sales into pharma/biotech/healthcare, and channel partnerships with major quantum hardware vendors that supply co-marketing reach. The primary customer segment is pharmaceutical and biotechnology firms seeking quantum-accelerated molecular simulation and drug-discovery workflows, supplemented by research institutions and government-funded quantum centres.

The company has raised €36 million in total funding, including a €18 million round in May 2026 led by United Ventures and Cassa Depositi e Prestiti (CDP) with Inventure VC participation — described as Italy's largest-ever venture capital investment in a quantum startup — alongside a $4M seed round in 2022 and a roughly $15M round in 2023 led by Inventure with the European Investment Bank, Tesi, Presidio Ventures and Thames Trust. Headcount is in the 11-50 range, with operations across Italy (HQ), Finland, UK, Ireland, and the US, led by co-founder/CEO Sabrina Maniscalco and a scientific founding team that publishes in Nature, Science, and Physical Review Letters. Algorithmiq reports being the first company to demonstrate quantum advantage on IBM hardware for a useful scientific problem.

Name

Algorithmiq

Legal name

Algorithmiq S.r.l.

Website

https://algorithmiq.fi

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Algorithmiq is a European quantum-software company that builds patented error-mitigation and chemistry algorithms (TEM, DQI, Aurora platform) running on IBM, Microsoft, Rigetti, QuEra and other quantum hardware, serving pharmaceutical, biotech, healthcare and research customers seeking quantum-accelerated molecular simulation and drug discovery.

Ownership category

akta.pro rank

Product category

Quantum Computing Software

NAICS

Computer Systems Design and Related Services (5415), Computer Systems Design Services (541512)

SIC

Services-Computer Programming Services (7371), Services-Computer Integrated Systems Design (7373), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Hybrid Quantum-Classical Orchestration & Workflow Management (HDAGAIAD)

akta.pro secondary industries

Hybrid Algorithm Frameworks & Libraries (VQE/QAOA/QML Tooling) (HDAGANAC), Quantum Cloud APIs, Billing & Metering (HDAGAIAJ), QCaaS Platforms & Developer Portals (HDAGAIAB), Domain-Specific Hybrid Application Platforms (Optimization/Finance/Chemistry/Logistics) (HDAGANAJ), Quantum Compilation Toolkits (Frontend SDK Layer) (HDAGACAF)

Keywords

• Quantum computing software
• Error mitigation algorithms
• Quantum chemistry simulation
• Drug discovery platforms
• Quantum life sciences

Headquarters

HQ city

Turku

HQ country

Finland

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Enterprise software licensing & client collaborations: Revenue generated from commercial agreements with enterprise customers (pharma, biotech, healthcare, research institutions) that license Algorithmiq's Aurora platform and engage in co-developed R&D projects; contract-based, relationship-driven revenue.
2. Marketplace / API-based usage: Revenue from access to Algorithmiq's quantum algorithms via cloud marketplaces such as the IBM Qiskit Functions Catalog and Microsoft Azure Quantum, where customers pay per-use or via subscription to run Algorithmiq's functions on quantum hardware.
3. Hardware-vendor partnerships: Joint development and commercial partnerships with quantum hardware providers (IBM, Microsoft, Rigetti, NVIDIA, QuEra, Quantum Circuits, OQI, OQC, Equal1) that may include co-marketing, co-selling, or revenue-share arrangements.
4. Grants and challenge prize income: Non-dilutive funding from research challenges and grants (e.g., Wellcome Leap Q4Bio Challenge $2M prize) that supplements R&D and validates the platform commercially.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels5 records

Core offering

Algorithmiq develops hybrid quantum-classical software, anchored by its Aurora quantum chemistry platform and the patented Digital Quantum Interface (DQI) and Tensor-network Error Mitigation (TEM), which enable chemically accurate simulations on noisy quantum hardware. The company sells enterprise licensing of Aurora, usage-based access to TEM and DQI through the IBM Qiskit Functions Catalog and Microsoft Azure Quantum, and bespoke R&D collaborations for drug discovery, molecular simulation, materials science, and quantum network medicine targeting pharma, biotech, healthcare, and research customers.

Product overview

Algorithmiq offers a platform-plus-modules architecture built around Aurora, its flagship quantum chemistry platform for life sciences, chemistry, and material sciences applications. Aurora integrates the Digital Quantum Interface (DQI) as its core engine for hybrid quantum-classical workflows and is complemented by several specialized toolboxes: the Measurement Toolbox, Error Mitigation Toolbox, and Circuit Optimisation Toolbox. The Tensor-network Error Mitigation (TEM) is a core component of the Aurora platform, also available as a standalone commercial service through IBM's Qiskit Functions Catalog. The platform enables applications in drug discovery (including the award-winning Q4Bio PDT workflow), quantum network medicine, drug metabolism prediction with QCI, and financial fraud detection with Rigetti, all targeting the industrialisation of quantum algorithms as Europe's strategic software layer.

Differentiator

Problem solved

Functional benefit

Brands

• Aurora: State-of-the-art quantum chemistry platform for molecular simulations in chemistry, material sciences, and life sciences, integrated with the Digital Quantum Interface.
• Digital Quantum Interface (DQI)
• Tensor-network Error Mitigation (TEM)

Products and services

• Aurora Aurora is Algorithmiq's state-of-the-art quantum chemistry platform for molecular simulations in chemistry, material sciences, and life sciences. Integrated with the Digital Quantum Interface (DQI), it enables ab-initio simulations based on quantum mechanics and applies quantum-inspired methods for data-driven solutions in bioinformatics and network medicine. It is targeted at pharma, biotech, materials, and life-sciences research customers.
• Digital Quantum Interface (DQI) DQI is Algorithmiq's patented framework that connects quantum computers with classical systems for hybrid quantum-classical workflows. It uses informationally complete measurements to post-process quantum computation results with tensor network algorithms on advanced HPC platforms. It is available as a callable function on the IBM Qiskit Functions Catalog and integrated with Microsoft's Quantum Development Kit.
• Tensor-network Error Mitigation (TEM) TEM is Algorithmiq's patented hybrid quantum-classical error-mitigation algorithm that mitigates noise entirely at the classical post-processing stage using informationally complete measurements processed through tensor networks representing the inverse of the noise channel. It is optimal with respect to theoretical bounds and demonstrated on circuits with up to 4,095 entangling gates and 91 qubits. TEM is commercially available as a standalone service through the IBM Qiskit Functions Catalog and is accelerated 300x by NVIDIA GPUs.
• Quantum Advantage Tracker Quantum Advantage Tracker is a public platform launched jointly by Algorithmiq and IBM with the Flatiron Institute and BlueQubit that provides open verification of quantum advantage claims. It publishes data, simulation scripts, and error-mitigation protocols to enable transparent evaluation of quantum advantage demonstrations on real hardware.

Quantifiable outcome

• First demonstrated quantum advantage on IBM hardware for a useful scientific problem
• +4 more outcomes

Named customers8 records

Segments2 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability7 records

Feature7 records

Partnerships

23 partnerships are on record, tiered flagship technology partner, core technology partner, minor strategic partner, minor technology partner, flagship research customer, core research partner and minor research partner.

• IBMflagship technology partnerStrategic or Co-development PartnerAlgorithmiq's algorithms are deployed on IBM quantum hardware and distributed via the IBM Qiskit Functions Catalog. The two companies have co-published quantum advantage results and 5 of 6 Q4Bio finalists ran on IBM hardware using Algorithmiq software.
• Microsoftflagship technology partnerStrategic or Co-development PartnerAlgorithmiq's quantum algorithms are integrated with Microsoft Azure Quantum, making them available to enterprise and research users on Microsoft's cloud platform.
• NVIDIAcore technology partnerStrategic or Co-development PartnerPartner for hybrid quantum–classical computing, leveraging NVIDIA GPU/HPC infrastructure alongside quantum hardware for accelerated quantum simulations.
• Rigetticore technology partnerStrategic or Co-development PartnerAlgorithmiq's algorithms run on Rigetti's superconducting quantum hardware as part of its hardware-agnostic deployment strategy.
• QuEracore technology partnerStrategic or Co-development PartnerNeutral-atom quantum hardware partner; Algorithmiq's algorithms are deployed on QuEra's quantum processors.
• Equal1minor strategic partnerStrategic or Co-development PartnerCo-development partner in the QUBIC project integrating Algorithmiq's algorithms on Equal1's quantum hardware.
• Googleminor technology partnerStrategic or Co-development PartnerReferenced as a partner in the quantum computing ecosystem relevant to Algorithmiq's work.
• AWSminor technology partnerStrategic or Co-development PartnerReferenced as a partner for cloud/quantum computing infrastructure relevant to Algorithmiq.
• Cleveland Clinicflagship research customerStrategic or Co-development PartnerResearch collaboration applying Algorithmiq's quantum algorithms to biomedical and life sciences problems.
• Fraunhofer ISCcore research partnerStrategic or Co-development PartnerResearch partnership on materials science and chemistry applications of quantum computing.
• CERNminor research partnerStrategic or Co-development PartnerResearch collaboration with CERN referenced as a partner in quantum algorithms and simulation.
• Flatiron Instituteminor research partnerStrategic or Co-development PartnerResearch collaboration with the Flatiron Institute on quantum algorithms and computational methods.
• EPFL (École polytechnique fédérale de Lausanne)core research partnerStrategic or Co-development PartnerAcademic research collaboration with EPFL on quantum computing science.
• Trinity College Dublinminor research partnerStrategic or Co-development PartnerResearch collaboration with Trinity College Dublin on quantum algorithms and chemistry.
• University of Ljubljanaminor research partnerStrategic or Co-development PartnerAcademic research collaboration with the University of Ljubljana.
• STFC / UK National Quantum Computing Centrecore research partnerStrategic or Co-development PartnerResearch collaboration with the UK's National Quantum Computing Centre, hosted at STFC.
• Harvard Universityminor research partnerStrategic or Co-development PartnerListed among research collaborators and trusted-by institutions.
• University of Oxfordminor research partnerStrategic or Co-development PartnerListed among research collaborators and trusted-by institutions.
• Imperial College Londonminor research partnerStrategic or Co-development PartnerListed among research collaborators and trusted-by institutions.
• University of Helsinkiminor research partnerStrategic or Co-development PartnerListed among research collaborators and trusted-by institutions.
• Aalto Universityminor research partnerStrategic or Co-development PartnerListed among research collaborators and trusted-by institutions.
• University of Milanminor research partnerStrategic or Co-development PartnerAcademic partner located near Algorithmiq's Milan headquarters.
• University of Copenhagenminor research partnerStrategic or Co-development PartnerListed among research collaborators and trusted-by institutions.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Classiq: Classiq provides a quantum software development platform with automated algorithm synthesis and hardware-agnostic compilation — directly competing with Algorithmiq's Aurora platform and Circuit Optimisation Toolbox for enterprise quantum software customers.
• QunaSys: QunaSys focuses on quantum chemistry algorithms and software (QunaSys Qamuy), targeting pharma and materials science — directly overlapping with Algorithmiq's Aurora chemistry and life sciences platform.
• Zapata Computing: Zapata (now QBio) builds enterprise quantum software platforms (Orquestra) for chemistry, optimisation, and machine learning — overlapping with Algorithmiq's hybrid quantum-classical workflow software for life sciences customers.
• QC Ware: QC Ware develops quantum algorithms and software (Prometheus) for chemistry, finance, and machine learning, distributed via cloud marketplaces — directly comparable to Algorithmiq's enterprise API-first go-to-market.
• Strangeworks: Strangeworks provides a quantum computing platform that aggregates access to multiple hardware backends and software tools — comparable to Algorithmiq's hardware-agnostic marketplace distribution model.

Broad incumbents

• Xanadu: Xanadu builds both quantum hardware (photonic) and a full software stack (PennyLane, Strawberry Fields, Borealis) — overlapping with Algorithmiq's quantum chemistry and ML workflows but operating as a broader incumbent.
• Quantinuum: Quantinuum combines trapped-ion quantum hardware with a full software stack (InQuanto for chemistry, TKET compiler) — competing with Algorithmiq in quantum chemistry and providing in-house alternatives to TEM/DQI.
• IBM Quantum: IBM Quantum is both Algorithmiq's largest distribution partner (via Qiskit Functions Catalog) and a potential competitor as it expands in-house error mitigation and quantum algorithm offerings — a critical incumbent in the same ecosystem.
• Microsoft Azure Quantum: Microsoft Azure Quantum is Algorithmiq's second major distribution partner (via QDK integration) and a competitor with its own quantum chemistry and algorithm efforts — an incumbent that could either expand or contract Algorithmiq's market access.

Emerging players

• Multiverse Computing: Multiverse Computing applies quantum and quantum-inspired algorithms to finance and optimisation — adjacent to Algorithmiq's emerging financial fraud detection work with Rigetti, and a fellow European quantum software peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/algorithmiq

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Funding overview

Funding rounds4 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Algorithmiq